Novartis has agreed to buy Regulus Therapeutics for up to $1.7 billion, giving the Swiss drugmaker access to an experimental ...

Despite the diagnosis, Valentina continued to grapple with cysts, severe pain, bloating, and heavy bleeding. Her personal ...

Ms Milanova, now 30, got her first period at just nine but, without any education about menstruation, feared she was gravely ...

Regulus Therapeutics will be acquired by Novartis AG for $7 per share in cash. Click here for more information on RGLS ...

Novartis has reached an agreement to buy Regulus Therapeutics and its experimental therapy for autosomal dominant polycystic ...

Valentina Milanova, 30, had her first period at nine years old and put on the pill at 11 after experiencing excruciating pain ...

At the heart of the acquisition is Regulus’ farabursen, an miRNA-targeting oligonucleotide in early-stage development for ...

Valentina Milanova believed she 'was dying' when she experienced her first period aged nine, but has since set up a business ...

Novartis Acquires Regulus Therapeutics in $1.7 Billion Deal for ADPKD Treatment ...

Shares of biopharmaceutical company Regulus Therapeutics Inc. (RGLS) shot up 138% at the opening bell on Wednesday after ...